TC
CABA icon

Truvestments Capital’s Cabaletta Bio CABA Stock Holding History

Truvestments Capital’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-680
Closed -$1.49K – 1182
2025
Q4 		$1.49K Hold
680
– – ﹤0.01% 898
2025
Q3 		$1.59K Sell
680
-1,293
-66% -$2.22K ﹤0.01% 935
2025
Q2 		$3K Hold
1,973
– – ﹤0.01% 795
2025
Q1 		$2.73K Sell
1,973
-358
-15% -$763 ﹤0.01% 829
2024
Q4 		$5.29K Buy
2,331
+1,565
+204% +$5.5K ﹤0.01% 691
2024
Q3 		$3.62K Buy
+766
New +$4.43K ﹤0.01% 725

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Truvestments Capital's CABA Position: Q1 2026 in Review

Truvestments Capital sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 680 shares — an estimated $1.49K sold.

Truvestments Capital first reported a position in CABA in Q3 2024 and held it in 6 quarters. The position peaked at $5.29K in Q4 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Truvestments Capital reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • Truvestments Capital sold 680 Cabaletta Bio shares in Q1 2026, an estimated $1.49K.
  • Truvestments Capital first reported a position in Cabaletta Bio in Q3 2024 and held it in 6 quarters.
  • Truvestments Capital's Cabaletta Bio position peaked at $5.29K in Q4 2024.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.